# Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

> **NCT03208309** · PHASE2 · COMPLETED · sponsor: **ANS Pharma** · enrollment: 40 (actual)

## Conditions studied

- Complications of Diabetes Mellitus
- Diabetes Mellitus
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Diacerein
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03208309
- **Lead sponsor:** ANS Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-07-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03208309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03208309, "Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03208309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*